What does Dr. De Clerck Matti, Neurologie do?

Dr. De Clerck Matti, Neurologie is a specialist medical practice in Langemark-Poelkapelle. Private Limited, started on 22 December 2008, 1 establishment.

What is the address of Dr. De Clerck Matti, Neurologie?

The registered office of Dr. De Clerck Matti, Neurologie is located at Kasteelstraat 26-28 box A31, 8920 Langemark-Poelkapelle.

Is Dr. De Clerck Matti, Neurologie still active?

Yes. According to the CBE (30 October 2026) Dr. De Clerck Matti, Neurologie is active, legal situation “Normale toestand”, started on 22 December 2008.

Is Dr. De Clerck Matti, Neurologie registered on Peppol?

Yes, Dr. De Clerck Matti, Neurologie is registered on the Peppol network with ID 0208:0808594770.

What is the enterprise number of Dr. De Clerck Matti, Neurologie?

The enterprise number of Dr. De Clerck Matti, Neurologie is BE0808594770.

When was Dr. De Clerck Matti, Neurologie founded?

Dr. De Clerck Matti, Neurologie was founded on 22 December 2008.

Who are the directors of Dr. De Clerck Matti, Neurologie?

According to the 2025 annual accounts, the directors of Dr. De Clerck Matti, Neurologie are: Matti De Clerck.

Is Dr. De Clerck Matti, Neurologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 December 2008; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. De Clerck Matti, Neurologie make in 2025?

Dr. De Clerck Matti, Neurologie posted a profit after taxes of € 73,507 in financial year 2025.

What is the revenue of Dr. De Clerck Matti, Neurologie?

As a small company, Dr. De Clerck Matti, Neurologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 131,778.

Dr. De Clerck Matti, Neurologie (Private Limited)

Dossier Dr. De Clerck Matti, Neurologie, printed on 30 October 2026 from databakkes.be/en/0808594770/dr-de-clerck-matti-neurologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. De Clerck Matti, Neurologie from Langemark-Poelkapelle, company number BE0808594770, closed financial year 2025 with a result of € 73,507 after tax. For that financial year Dr. De Clerck Matti, Neurologie recorded a gross margin of € 131,778 and equity of € 324,713. Compared with financial year 2024, the result moved from € 45,431 to € 73,507. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.

What it is worth Growing

€ 324,713

▲ 29% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 73,507

▲ 62% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 118,277

▲ 1% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 324,713.

People and assets in 2025

Wage cost

€ 19,427

▼ 15% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 3,153

▼ 38% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 25,677

▼ 9% vs 2024

€ 17,762 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 418

▼ 37% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 15,493

▲ 40% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 142,227 Gross margin 2022: € 142,227 First fiscal year in the series	€ 124,976 Gross margin 2023: € 124,976 ▼ 12% vs 2022 (€ 142,227) Unfavourable step	€ 96,578 Gross margin 2024: € 96,578 ▼ 23% vs 2023 (€ 124,976) Unfavourable step	€ 131,778 Gross margin 2025: € 131,778 ▲ 36% vs 2024 (€ 96,578) Favourable step	▲ 36%
Profit after taxes	€ 81,326 Profit after taxes 2022: € 81,326 First fiscal year in the series	€ 65,789 Profit after taxes 2023: € 65,789 ▼ 19% vs 2022 (€ 81,326) Unfavourable step	€ 45,431 Profit after taxes 2024: € 45,431 ▼ 31% vs 2023 (€ 65,789) Unfavourable step	€ 73,507 Profit after taxes 2025: € 73,507 ▲ 62% vs 2024 (€ 45,431) Favourable step	▲ 62%
Equity	€ 166,986 Equity 2022: € 166,986 First fiscal year in the series	€ 232,775 Equity 2023: € 232,775 ▲ 39% vs 2022 (€ 166,986) Favourable step	€ 251,206 Equity 2024: € 251,206 ▲ 8% vs 2023 (€ 232,775) Favourable step	€ 324,713 Equity 2025: € 324,713 ▲ 29% vs 2024 (€ 251,206) Favourable step	▲ 29%
Total debts	€ 104,624 Total debts 2022: € 104,624 First fiscal year in the series	€ 63,894 Total debts 2023: € 63,894 ▼ 39% vs 2022 (€ 104,624) Favourable step	€ 64,748 Total debts 2024: € 64,748 ▲ 1% vs 2023 (€ 63,894) Unfavourable step	€ 41,588 Total debts 2025: € 41,588 ▼ 36% vs 2024 (€ 64,748) Favourable step	▼ 36%
Cash	€ 52,987 Cash 2022: € 52,987 First fiscal year in the series	€ 70,433 Cash 2023: € 70,433 ▲ 33% vs 2022 (€ 52,987) Favourable step	€ 117,181 Cash 2024: € 117,181 ▲ 66% vs 2023 (€ 70,433) Favourable step	€ 118,277 Cash 2025: € 118,277 ▲ 1% vs 2024 (€ 117,181) Favourable step	▲ 1%
Land & buildings	-	-	-	€ 2,553 Land & buildings 2025: € 2,553 First fiscal year in the series
Retained profit	€ 166,986 Retained profit 2022: € 166,986 First fiscal year in the series	€ 232,775 Retained profit 2023: € 232,775 ▲ 39% vs 2022 (€ 166,986) Favourable step	€ 251,206 Retained profit 2024: € 251,206 ▲ 8% vs 2023 (€ 232,775) Favourable step	€ 324,713 Retained profit 2025: € 324,713 ▲ 29% vs 2024 (€ 251,206) Favourable step	▲ 29%
Dividend	€ 40,000 Dividend 2022: € 40,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 40,000) Unchanged	€ 27,000 Dividend 2024: € 27,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 27,000) Unchanged	▼ 100%
Bank debt	€ 33,415 Bank debt 2022: € 33,415 First fiscal year in the series	€ 30,935 Bank debt 2023: € 30,935 ▼ 7% vs 2022 (€ 33,415) Favourable step	€ 28,342 Bank debt 2024: € 28,342 ▼ 8% vs 2023 (€ 30,935) Favourable step	€ 25,677 Bank debt 2025: € 25,677 ▼ 9% vs 2024 (€ 28,342) Favourable step	▼ 9%
Balance sheet total	€ 271,610 Balance sheet total 2022: € 271,610 First fiscal year in the series	€ 296,669 Balance sheet total 2023: € 296,669 ▲ 9% vs 2022 (€ 271,610) Unchanged	€ 315,954 Balance sheet total 2024: € 315,954 ▲ 7% vs 2023 (€ 296,669) Unchanged	€ 366,301 Balance sheet total 2025: € 366,301 ▲ 16% vs 2024 (€ 315,954) Unchanged	▲ 16%

Key figures of Dr. De Clerck Matti, Neurologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. De Clerck Matti, Neurologie?

What happened at Dr. De Clerck Matti, Neurologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 28, 2026 New annual accounts for financial year 2025: profit of € 73,507 (▲ 62% vs 2024). Source: NBB ↗
2022 Matti De Clerck became a director. NBB
Dec 22, 2008 New establishment in Ninove. KBO
Dec 22, 2008 Start of the company according to the CBE. KBO

In short

From € 81,326 profit in 2022 to € 73,507 profit in 2025.

Paid € 104,949 in corporate taxes since 2022.

Best year ever: 2022, with € 81,326 profit.

Paid out € 67,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Matti De Clerck

Dr. De Clerck Matti, Neurologie

Neurologie ASZ 16.7%

Neurologie AZORG 12.5%

Behind Dr. De Clerck Matti, Neurologie is Matti De Clerck. It owns 16.7% of Neurologie ASZ and 12.5% of Neurologie AZORG itself.

Directors

According to the 2025 annual accounts

Matti De Clerck

Director

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Kasteelstraat 26-28 box A31

8920 Langemark-Poelkapelle

2.258.572.942

Neerstraat(App) 94

9400 Ninove

Active since 22 December 2008

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

VERENIGING VAN MEDE-EIGENAARS RESIDENTIE KASTEELVIJVER TE LANGEMARK-POELKAPELLE, KASTEELSTRAAT 26A/B EN 28A/B

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0808.594.770
VAT number: BE 0808.594.770
Registered office: Kasteelstraat 26-28 bus A31, 8920 Langemark-Poelkapelle
Names & denominations: Dr. De Clerck Matti, Neurologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 December 2008
Peppol: Active · Active since 29 Jun 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗